$PLXS
PLEXUS CORP Stock $plxs

$plxs Overview Financials Valuation SEC Filings Company Website

2017 Q3 Form 10-Q Financial Statement

#000078578617000042 Filed on August 04, 2017

Income Statement

Concept	2017 Q3	2016 Q4	2016 Q3
Revenue	$669.9M	$635.0M	$667.6M
YoY Change	0.33%	-5.04%	-0.29%
Cost Of Revenue	$557.6M	$570.7M	$605.1M
YoY Change	-7.84%	-6.37%	-0.88%
Gross Profit	$66.51M	$64.36M	$62.50M
YoY Change	6.43%	8.58%	5.77%
Gross Profit Margin	9.93%	10.13%	9.36%
Selling, General & Admin	$31.72M	$30.45M	$29.78M
YoY Change	6.52%	-0.8%	-2.24%
% of Gross Profit	47.68%	47.32%	47.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$11.30M	$11.45M	$11.90M
YoY Change	-5.04%	-3.79%	0.0%
% of Gross Profit	16.99%	17.79%	19.04%
Operating Expenses	$31.72M	$30.45M	$29.78M
YoY Change	6.52%	-0.8%	-2.24%
Operating Profit	$29.47M	$33.90M	$30.92M
YoY Change	-4.69%	18.66%	7.99%
Interest Expense	$3.294M	$3.274M	$3.637M
YoY Change	-9.43%	-225.92%	10.88%
% of Operating Profit	11.18%	9.66%	11.76%
Other Income/Expense, Net	-$103.0K	-$674.0K	$297.0K
YoY Change	-134.68%	-184.25%	-36.94%
Pretax Income	$27.37M	$31.03M	$28.71M
YoY Change	-4.67%	15.77%	7.58%
Income Tax	$1.792M	$2.847M	$2.613M
% Of Pretax Income	6.55%	9.18%	9.1%
Net Earnings	$29.01M	$28.18M	$26.10M
YoY Change	11.15%	18.08%	9.69%
Net Earnings / Revenue	4.33%	4.44%	3.91%
Basic Earnings Per Share	$0.86	$0.84	$0.78
Diluted Earnings Per Share	$0.84	$0.82	$0.76
COMMON SHARES
Basic Shares Outstanding	33.67M shares	33.53M shares	33.40M shares
Diluted Shares Outstanding	34.57M shares	34.54M shares	34.17M shares

Balance Sheet

Concept	2017 Q3	2016 Q4	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$519.2M	$433.0M	$433.7M
YoY Change	19.71%	21.25%	22.24%
Cash & Equivalents	$568.9M	$433.0M	$433.7M
Short-Term Investments
Other Short-Term Assets	$30.40M	$19.40M	$35.80M
YoY Change	-15.08%	-15.28%	10.49%
Inventory	$654.6M	$564.1M	$575.1M
Prepaid Expenses
Receivables	$365.5M	$416.9M	$375.2M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.617B	$1.433B	$1.420B
YoY Change	13.92%	7.44%	7.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$314.7M	$291.2M	$300.8M
YoY Change	4.6%	-8.23%	-6.82%
Goodwill
YoY Change
Intangibles	$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets	$38.77M	$36.41M	$36.73M
YoY Change	5.55%	1.96%	-8.88%
Total Long-Term Assets	$358.7M	$332.5M	$341.1M
YoY Change	5.17%	-7.06%	-6.97%
TOTAL ASSETS
Total Short-Term Assets	$1.617B	$1.433B	$1.420B
Total Long-Term Assets	$358.7M	$332.5M	$341.1M
Total Assets	$1.976B	$1.766B	$1.761B
YoY Change	12.22%	4.38%	4.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$414.0M	$397.2M	$410.5M
YoY Change	0.84%	-0.88%	-1.36%
Accrued Expenses	$90.70M	$89.50M	$81.80M
YoY Change	10.88%	6.8%	2.89%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$267.3M	$78.50M	$78.30M
YoY Change	241.38%	2142.86%	1720.93%
Total Short-Term Liabilities	$907.6M	$650.4M	$658.3M
YoY Change	37.87%	12.28%	13.44%
LONG-TERM LIABILITIES
Long-Term Debt	$26.10M	$184.0M	$184.5M
YoY Change	-85.85%	-28.77%	-28.84%
Other Long-Term Liabilities	$16.48M	$14.58M	$13.92M
YoY Change	18.41%	22.59%	12.42%
Total Long-Term Liabilities	$42.65M	$198.6M	$207.5M
YoY Change	-79.44%	-26.5%	-25.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$907.6M	$650.4M	$658.3M
Total Long-Term Liabilities	$42.65M	$198.6M	$207.5M
Total Liabilities	$950.2M	$849.0M	$865.8M
YoY Change	9.76%	-0.05%	1.0%
SHAREHOLDERS EQUITY
Retained Earnings	$1.049B	$937.1M	$918.1M
YoY Change	14.29%	8.88%	9.7%
Common Stock	$519.0K	$513.0K	$511.0K
YoY Change	1.57%	1.38%	1.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$563.8M	$540.0M	$532.9M
YoY Change	5.81%	5.88%	6.05%
Treasury Stock Shares	18.27M shares	17.82M shares	17.66M shares
Shareholders Equity	$1.026B	$916.8M	$895.2M
YoY Change
Total Liabilities & Shareholders Equity	$1.976B	$1.766B	$1.761B
YoY Change	12.22%	4.38%	4.06%

Cashflow Statement

Concept	2017 Q3	2016 Q4	2016 Q3
OPERATING ACTIVITIES
Net Income	$29.01M	$28.18M	$26.10M
YoY Change	11.15%	18.08%	9.69%
Depreciation, Depletion And Amortization	$11.30M	$11.45M	$11.90M
YoY Change	-5.04%	-3.79%	0.0%
Cash From Operating Activities	$16.30M	$79.45M	$31.30M
YoY Change	-47.92%	278.34%	110.07%
INVESTING ACTIVITIES
Capital Expenditures	-$9.800M	$6.950M	-$7.000M
YoY Change	40.0%	-184.76%	-31.37%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$4.600M	$0.00
YoY Change		4500.0%	-100.0%
Cash From Investing Activities	-$9.800M	-$6.826M	-$6.900M
YoY Change	42.03%	-15.73%	-31.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$9.950M	$7.061M	$7.200M
YoY Change	38.19%		-4.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-13.50M	-$4.175M	1.500M
YoY Change	-1000.0%	-50.3%	-188.24%
NET CHANGE
Cash From Operating Activities	16.30M	$79.45M	31.30M
Cash From Investing Activities	-9.800M	-$6.826M	-6.900M
Cash From Financing Activities	-13.50M	-$4.175M	1.500M
Net Change In Cash	-7.000M	$64.88M	25.90M
YoY Change	-127.03%	1341.84%	709.38%
FREE CASH FLOW
Cash From Operating Activities	$16.30M	$79.45M	$31.30M
Capital Expenditures	-$9.800M	$6.950M	-$7.000M
Free Cash Flow	$26.10M	$72.50M	$38.30M
YoY Change	-31.85%	148.29%	52.59%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000785786
	plxs	Amount Received From Trade Accounts Receivable Sold To Third Party AmountReceivedFromTradeAccountsReceivableSoldToThirdParty	53700000	USD
CY2017Q3	plxs	Amount Received From Trade Accounts Receivable Sold To Third Party AmountReceivedFromTradeAccountsReceivableSoldToThirdParty	114600000	USD
CY2017Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33600857	shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-07-01
	dei	Document Type DocumentType	10-Q
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	PLEXUS CORP
CY2016Q3	plxs	Amount Received From Trade Accounts Receivable Sold To Third Party AmountReceivedFromTradeAccountsReceivableSoldToThirdParty	12600000	USD
	plxs	Amount Received From Trade Accounts Receivable Sold To Third Party AmountReceivedFromTradeAccountsReceivableSoldToThirdParty	283100000	USD
CY2015Q4	plxs	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents CashCashEquivalentsRestrictedCashandRestrictedCashEquivalents	357106000	USD
CY2016Q3	plxs	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents CashCashEquivalentsRestrictedCashandRestrictedCashEquivalents	433679000	USD
CY2016Q4	plxs	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents CashCashEquivalentsRestrictedCashandRestrictedCashEquivalents	432964000	USD
CY2017Q3	plxs	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents CashCashEquivalentsRestrictedCashandRestrictedCashEquivalents	519959000	USD
	plxs	Cash Cash Equivalentsand Restricted Cash Period Increase Decrease CashCashEquivalentsandRestrictedCashPeriodIncreaseDecrease	76573000	USD
	plxs	Cash Cash Equivalentsand Restricted Cash Period Increase Decrease CashCashEquivalentsandRestrictedCashPeriodIncreaseDecrease	86995000	USD
CY2016Q3	plxs	Trade Accounts Receivable Sold TradeAccountsReceivableSold	12700000	USD
	plxs	Trade Accounts Receivable Sold TradeAccountsReceivableSold	54200000	USD
CY2017Q3	plxs	Trade Accounts Receivable Sold TradeAccountsReceivableSold	115300000	USD
	plxs	Trade Accounts Receivable Sold TradeAccountsReceivableSold	284600000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	397200000	USD
CY2017Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	394220000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	416888000	USD
CY2017Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	318168000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-11539000	USD
CY2017Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-13171000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	530647000	USD
CY2017Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	547586000	USD
CY2016Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3600000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10600000	USD
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4500000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8899000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-696000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	9358000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1632000	USD
CY2017Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	1433347000	USD
CY2017Q3	us-gaap	Assets Current AssetsCurrent	1520809000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12500000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2368000	USD
CY2017Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1801000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	243000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	233000	USD
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	500000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	700000	shares
CY2017Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
CY2016Q4	us-gaap	Assets Assets	1765819000	USD
CY2017Q3	us-gaap	Assets Assets	1868632000	USD
CY2016Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	332472000	USD
CY2017Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	347823000	USD
CY2016Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	13614000	USD
CY2017Q3	us-gaap	Capital Lease Obligations CapitalLeaseObligations	31307000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	432964000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	519172000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	51272000	shares
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	51856000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33457000	shares
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33583000	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	513000	USD
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	519000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	17200000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	56638000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	34937000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	81421000	USD
CY2016Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	605118000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1737111000	USD
CY2017Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	557647000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1668859000	USD
CY2016Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	84637000	USD
CY2017Q3	us-gaap	Customer Deposits Current CustomerDepositsCurrent	81326000	USD
CY2016Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	262509000	USD
CY2017Q3	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	293435000	USD
CY2016Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	251400000	USD
CY2017Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	263400000	USD
CY2016Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	250000000	USD
CY2017Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	263000000	USD
CY2016Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1105000	USD
CY2017Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	872000	USD
CY2016Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4834000	USD
CY2017Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4786000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	142000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	86000	USD
	us-gaap	Depreciation Depreciation	35789000	USD
	us-gaap	Depreciation Depreciation	33785000	USD
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.78
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.72
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.76
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.47
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.76
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.68
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.74
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.40
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-3819000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-735000	USD
CY2016Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.091	Rate
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7762000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.126	Rate
CY2017Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.065	Rate
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.085	Rate
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	41806000	USD
CY2017Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	46844000	USD
CY2016Q4	us-gaap	Foreign Currency Derivative Instruments Not Designated As Hedging Instruments At Fair Value Net ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet	52000	USD
CY2017Q3	us-gaap	Foreign Currency Derivative Instruments Not Designated As Hedging Instruments At Fair Value Net ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet	149000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-267000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	24000	USD
CY2016Q3	us-gaap	Gross Profit GrossProfit	62498000	USD
	us-gaap	Gross Profit GrossProfit	165829000	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	61185000	USD
	us-gaap	Gross Profit GrossProfit	189341000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	28712000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	65573000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	27371000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	90815000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2613000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8239000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1792000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	18173000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-6414000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4985000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-98404000	USD
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	7016000	USD
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	-3370000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11340000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	87824000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	476000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	10731000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-120000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2240000	USD
CY2016Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	772000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	664000	shares
CY2017Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	899000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	949000	shares
CY2016Q3	us-gaap	Interest Expense InterestExpense	3637000	USD
	us-gaap	Interest Expense InterestExpense	10845000	USD
CY2017Q3	us-gaap	Interest Expense InterestExpense	3294000	USD
	us-gaap	Interest Expense InterestExpense	9830000	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	80405000	USD
CY2017Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	99304000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	564131000	USD
CY2017Q3	us-gaap	Inventory Net InventoryNet	653101000	USD
CY2016Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	414303000	USD
CY2017Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	479634000	USD
CY2016Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	69423000	USD
CY2017Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	74163000	USD
CY2016Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1134000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	3081000	USD
CY2017Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1299000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	3555000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	849022000	USD
CY2017Q3	us-gaap	Liabilities Liabilities	877326000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1765819000	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1868632000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	650436000	USD
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	835136000	USD
CY2016Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	198586000	USD
CY2017Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	42190000	USD
CY2016Q4	us-gaap	Line Of Credit LineOfCredit	75000000	USD
CY2017Q3	us-gaap	Line Of Credit LineOfCredit	88000000	USD
	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	99400000	USD
CY2017Q3	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	300000000	USD
CY2017Q3	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2021-07-05
CY2017Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	500000000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	184002000	USD
CY2017Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	26138000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	78507000	USD
CY2017Q3	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	267297000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-18492000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10186000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-23728000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24007000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	122612000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	121923000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	26099000	USD
	us-gaap	Net Income Loss NetIncomeLoss	57334000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	25579000	USD
	us-gaap	Net Income Loss NetIncomeLoss	83053000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	30918000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	75788000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	29469000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	95943000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	36413000	USD
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	37274000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-7570000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-13154000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	6367000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2379000	USD
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q3	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-1329000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	12458000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	2991000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	747000	USD
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	48286000	USD
CY2017Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	45449000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14584000	USD
CY2017Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16052000	USD
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	297000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2451000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-103000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1147000	USD
CY2017Q2	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	10300000	USD
CY2017Q3	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	15700000	USD
CY2017Q3	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-1500000	USD
CY2016Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	7200000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	22914000	USD
CY2017Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	9950000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	23856000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	70000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2582000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	6141000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	23776000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	24443000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19364000	USD
CY2017Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	29581000	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	453000000	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	166087000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	48000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	436000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11162000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10601000	USD
CY2015Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	5847000	USD
CY2016Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	6109000	USD
CY2017Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	4925000	USD
CY2016	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1515000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	2074000	USD
CY2016	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1777000	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	890000	USD
CY2016Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	29775000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	84812000	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1020196000	USD
CY2016Q3	us-gaap	Sales Revenue Net SalesRevenueNet	667616000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	1902940000	USD
CY2017Q3	us-gaap	Sales Revenue Net SalesRevenueNet	618832000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	1858200000	USD
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	31716000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	93398000	USD
CY2016Q4	us-gaap	Senior Notes SeniorNotes	175000000	USD
CY2017Q3	us-gaap	Senior Notes SeniorNotes	175000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	10599000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	291225000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	305763000	USD
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	457088000	USD
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	156877000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2017Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	787000	USD
CY2016Q3	us-gaap	Restructuring Charges RestructuringCharges	1805000	USD
	us-gaap	Restructuring Charges RestructuringCharges	5229000	USD
CY2017Q3	us-gaap	Restructuring Charges RestructuringCharges	0	USD
	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2015Q4	us-gaap	Restructuring Reserve RestructuringReserve	0	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	937144000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	12485000	USD
CY2015Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	30000000	USD
CY2016Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	150000000	USD
CY2016Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	170355	shares
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	606236	shares
CY2017Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	189891	shares
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	457702	shares
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	916797000	USD
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	991306000	USD
CY2016Q3	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	42.13
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	37.80
CY2017Q3	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	52.40
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	52.12
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	17815000	shares
CY2017Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	18273000	shares
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	539968000	USD
CY2017Q3	us-gaap	Treasury Stock Value TreasuryStockValue	563824000	USD
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34174000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34043000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34568000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34585000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33379000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33402000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33669000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33636000	shares
	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">New Accounting Pronouncements</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2016, the Financial Accounting Standards Board (“FASB”) issued amendments to its guidance to address the classifications and presentation of changes in restricted cash in the statement of cash flows. The Company adopted this guidance retrospectively during the first quarter of fiscal 2017 and, as a result, the Company included restricted cash within the Consolidated Statements of Cash Flows; such amounts were not material. The retrospective adoption did not impact the prior period Consolidated Statements of Cash Flows since there was no restricted cash during any of the prior periods presented. Amounts included in restricted cash represent cash received from customers to settle invoices sold under the trade accounts receivable sale programs and is therefore contractually required to be set aside. The restrictions will lapse when the cash is remitted to the purchaser.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2016, the FASB issued a new accounting standard intended to improve the accounting for the income tax consequences of intra-entity transfers of assets other than inventory. The new standard eliminates the exception for an intra-entity transfer of an asset other than inventory and requires an entity to recognize the income tax consequences when the transfer occurs. This guidance is effective for the Company beginning in the first quarter of fiscal year 2019 and early adoption is permitted. This guidance should be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. The Company is currently assessing the impact this new standard may have on its Consolidated Financial Statements.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2016, the FASB issued new guidance related to the classification of certain cash receipts and cash payments, which clarifies how entities should classify certain cash receipts and cash payments on the statement of cash flows. The new standard addresses certain issues where diversity in practice was identified. It also amends existing guidance, which is principles based and often requires judgment to determine the appropriate classification of cash flows as operating, investing or financing activities and clarifies how the predominance principle should be applied when cash receipts and cash payments have aspects of more than one class of cash flows. This guidance is effective for the Company beginning in the first quarter of fiscal year 2019, and will generally require retrospective adoption. Early adoption is permitted. The Company is currently assessing the impact this new standard may have on its Consolidated Statements of Cash Flows.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, the FASB issued guidance that changes the accounting for certain aspects of share-based payments to employees. The guidance requires the recognition of the income tax effects of awards in the income statement when the awards vest or are settled, thus eliminating additional paid-in capital pools. The guidance also allows for the employer to repurchase more of an employee’s shares for tax withholding purposes without triggering liability accounting. In addition, the guidance allows for a policy election to account for forfeitures as they occur rather than on an estimated basis. The Company adopted this guidance prospectively during the first fiscal quarter of 2017. As such, beginning in the first fiscal quarter of 2017, the Company recognizes all excess tax benefits and tax deficiencies as income tax benefit or expense as a discrete item. An income tax benefit of approximately </font><font style="font-family:inherit;font-size:10pt;">$4.9 million</font><font style="font-family:inherit;font-size:10pt;"> was recognized upon adoption, and for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">July 1, 2017</font><font style="font-family:inherit;font-size:10pt;">, benefits of </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, were also recognized. Due to the Company having a valuation allowance in the jurisdictions in which the income tax benefit was recorded, the income tax benefit was directly offset by an increase to the Company's valuation allowance resulting in no financial statement impact. The adoption did not have any other material impacts and will not materially impact the Company's future financial statements as long as the Company remains in a valuation allowance in the jurisdictions in which share-based compensation awards and options vest and are exercised, respectively. </font></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued guidance that primarily requires lessees to recognize most leases on their balance sheets but record expenses on their income statements in a manner similar to current accounting. For lessors, the guidance modifies the classification criteria and the accounting for sales-type and direct financing leases. The guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption is permitted. The Company is currently in the process of assessing the impact of the adoption of the new standard on its Consolidated Financial Statements and the timing of adoption.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued new guidance which requires an entity to recognize revenue relating to contracts with customers that depicts the transfer of promised goods or services to customers in an amount reflecting the consideration to which the entity expects to be entitled in exchange for such goods or services. The guidance also requires disclosures enabling users of financial statements to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers and is effective for the Company beginning in the first quarter of fiscal year 2019. The Company has determined that the new standard will result in a change to the timing of revenue recognition for a significant portion of the Company's revenue stream, whereby revenue will be recognized "over time" as opposed to at a "point in time" upon physical delivery. The new standard could have a material impact on the Company's consolidated financial statements upon initial adoption, primarily as the Company recognizes an increase in contract assets for unbilled receivables with a corresponding reduction in finished goods and work-in-process inventory. The Company has commenced implementation in accordance with the planned effective date. The new guidance allows for two transition methods in application - (i) retrospective to each prior reporting period presented, or (ii) prospective with the cumulative effect of adoption recognized on September 30, 2018, the first day of the Company's fiscal year 2019. The Company has not yet selected its transition method.</font></div></div>

Files In Submission

Name	View Source	Status
0000785786-17-000042-index-headers.html	Edgar Link	pending
0000785786-17-000042-index.html	Edgar Link	pending
0000785786-17-000042.txt	Edgar Link	pending
0000785786-17-000042-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
plexuslogoa03.jpg	Edgar Link	pending
plxs-20170701.xml	Edgar Link	completed
plxs-20170701.xsd	Edgar Link	pending
plxs-20170701_cal.xml	Edgar Link	unprocessable
plxs-20170701_def.xml	Edgar Link	unprocessable
plxs-20170701_lab.xml	Edgar Link	unprocessable
plxs-20170701_pre.xml	Edgar Link	unprocessable
plxs-2017x10qxq3xex311.htm	Edgar Link	pending
plxs-2017x10qxq3xex312.htm	Edgar Link	pending
plxs-2017x10qxq3xex321.htm	Edgar Link	pending
plxs-2017x10qxq3xex322.htm	Edgar Link	pending
plxs-2017x10qxq3xex991.htm	Edgar Link	pending
plxs-712017x10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PLXS
PLEXUS CORP Stock $plxs

2017 Q3 Form 10-Q Financial Statement

#000078578617000042 Filed on August 04, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLXS PLEXUS CORP Stock $plxs

2017 Q3 Form 10-Q Financial Statement

#000078578617000042 Filed on August 04, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLXS
PLEXUS CORP Stock $plxs